Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Ebi3 Prevents Trypanosoma cruzi-Induced Myocarditis by Dampening IFN-γ-Driven Inflammation.

Medina TS, Oliveira GG, Silva MC, David BA, Silva GK, Fonseca DM, Sesti-Costa R, Frade AF, Baron MA, Ianni B, Pereira AC, Chevillard C, Cunha-Neto E, Marin-Neto JA, Silva JS.

Front Immunol. 2017 Sep 26;8:1213. doi: 10.3389/fimmu.2017.01213. eCollection 2017.

2.

The Significance of Discordant Serology in Chagas Disease: Enhanced T-Cell Immunity to Trypanosoma cruzi in Serodiscordant Subjects.

Castro Eiro MD, Alvarez MG, Cooley G, Viotti RJ, Bertocchi GL, Lococo B, Albareda MC, De Rissio AM, Natale MA, Parodi C, Tarleton RL, Laucella SA.

Front Immunol. 2017 Sep 15;8:1141. doi: 10.3389/fimmu.2017.01141. eCollection 2017.

3.

Costimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective Immunity.

Eickhoff CS, Zhang X, Vasconcelos JR, Motz RG, Sullivan NL, O'Shea K, Pozzi N, Gohara DW, Blase JR, Di Cera E, Hoft DF.

PLoS Pathog. 2016 Sep 19;12(9):e1005896. doi: 10.1371/journal.ppat.1005896. eCollection 2016 Sep.

4.

The Aryl Hydrocarbon Receptor Modulates Production of Cytokines and Reactive Oxygen Species and Development of Myocarditis during Trypanosoma cruzi Infection.

Barroso A, Gualdrón-López M, Esper L, Brant F, Araújo RR, Carneiro MB, Ávila TV, Souza DG, Vieira LQ, Rachid MA, Tanowitz HB, Teixeira MM, Machado FS.

Infect Immun. 2016 Sep 19;84(10):3071-82. doi: 10.1128/IAI.00575-16. Print 2016 Oct.

5.

Treatment Success in Trypanosoma cruzi Infection Is Predicted by Early Changes in Serially Monitored Parasite-Specific T and B Cell Responses.

Alvarez MG, Bertocchi GL, Cooley G, Albareda MC, Viotti R, Perez-Mazliah DE, Lococo B, Castro Eiro M, Laucella SA, Tarleton RL.

PLoS Negl Trop Dis. 2016 Apr 29;10(4):e0004657. doi: 10.1371/journal.pntd.0004657. eCollection 2016 Apr.

6.

A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease.

Barry MA, Wang Q, Jones KM, Heffernan MJ, Buhaya MH, Beaumier CM, Keegan BP, Zhan B, Dumonteil E, Bottazzi ME, Hotez PJ.

Hum Vaccin Immunother. 2016 Apr 2;12(4):976-87. doi: 10.1080/21645515.2015.1119346. Epub 2016 Feb 18.

7.

Trypanosoma cruzi Causes Paralyzing Systemic Necrotizing Vasculitis Driven by Pathogen-Specific Type I Immunity in Mice.

Roffê E, Marino AP, Weaver J, Wan W, de Araújo FF, Hoffman V, Santiago HC, Murphy PM.

Infect Immun. 2016 Mar 24;84(4):1123-36. doi: 10.1128/IAI.01497-15. Print 2016 Apr.

8.

An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8(+) T cell epitopes.

Eickhoff CS, Van Aartsen D, Terry FE, Meymandi SK, Traina MM, Hernandez S, Martin WD, Moise L, De Groot AS, Hoft DF.

Hum Vaccin Immunother. 2015;11(9):2322-8. doi: 10.1080/21645515.2015.1061160. Epub 2015 Jun 24.

9.

Modulation of Trypanosoma cruzi-specific T-cell responses after chemotherapy for chronic Chagas disease.

Albareda MC, Laucella SA.

Mem Inst Oswaldo Cruz. 2015 May;110(3):414-21. doi: 10.1590/0074-02760140386. Review.

10.

A Two-Component DNA-Prime/Protein-Boost Vaccination Strategy for Eliciting Long-Term, Protective T Cell Immunity against Trypanosoma cruzi.

Gupta S, Garg NJ.

PLoS Pathog. 2015 May 7;11(5):e1004828. doi: 10.1371/journal.ppat.1004828. eCollection 2015 May.

11.

Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives.

Pinazo MJ, Thomas MC, Bustamante J, Almeida IC, Lopez MC, Gascon J.

Mem Inst Oswaldo Cruz. 2015 May;110(3):422-32. doi: 10.1590/0074-02760140435. Epub 2015 Apr 28. Review.

12.

Differential phenotypic and functional profiles of TcCA-2 -specific cytotoxic CD8+ T cells in the asymptomatic versus cardiac phase in Chagasic patients.

Egui A, Thomas MC, Carrilero B, Segovia M, Alonso C, Marañón C, López MC.

PLoS One. 2015 Mar 27;10(3):e0122115. doi: 10.1371/journal.pone.0122115. eCollection 2015.

13.

Perturbed T cell IL-7 receptor signaling in chronic Chagas disease.

Albareda MC, Perez-Mazliah D, Natale MA, Castro-Eiro M, Alvarez MG, Viotti R, Bertocchi G, Lococo B, Tarleton RL, Laucella SA.

J Immunol. 2015 Apr 15;194(8):3883-9. doi: 10.4049/jimmunol.1402202. Epub 2015 Mar 13.

14.

Depletion of regulatory T cells decreases cardiac parasitosis and inflammation in experimental Chagas disease.

Bonney KM, Taylor JM, Thorp EB, Epting CL, Engman DM.

Parasitol Res. 2015 Mar;114(3):1167-78. doi: 10.1007/s00436-014-4300-3. Epub 2015 Jan 11.

15.

Low frequency of circulating CD8+ T stem cell memory cells in chronic chagasic patients with severe forms of the disease.

Mateus J, Lasso P, Pavia P, Rosas F, Roa N, Valencia-Hernández CA, González JM, Puerta CJ, Cuéllar A.

PLoS Negl Trop Dis. 2015 Jan 8;9(1):e3432. doi: 10.1371/journal.pntd.0003432. eCollection 2015 Jan.

16.

Circulating serum markers and QRS scar score in Chagas cardiomyopathy.

Clark EH, Marks MA, Gilman RH, Fernandez AB, Crawford TC, Samuels AM, Hidron AI, Galdos-Cardenas G, Menacho-Mendez GS, Bozo-Gutierrez RW, Martin DL, Bern C.

Am J Trop Med Hyg. 2015 Jan;92(1):39-44. doi: 10.4269/ajtmh.14-0246. Epub 2014 Nov 10.

17.

Presence of antigen-experienced T cells with low grade of differentiation and proliferative potential in chronic Chagas disease myocarditis.

Argüello RJ, Vigliano C, Cabeza-Meckert P, Viotti R, Garelli F, Favaloro LE, Favaloro RR, Laguens R, Laucella SA.

PLoS Negl Trop Dis. 2014 Aug 21;8(8):e2989. doi: 10.1371/journal.pntd.0002989. eCollection 2014 Aug.

18.

CD8(+) T cell-mediated immunity during Trypanosoma cruzi infection: a path for vaccine development?

Dos Santos Virgilio F, Pontes C, Dominguez MR, Ersching J, Rodrigues MM, Vasconcelos JR.

Mediators Inflamm. 2014;2014:243786. doi: 10.1155/2014/243786. Epub 2014 Jul 1. Review.

19.

CD8+ T Cell Responses to Plasmodium and Intracellular Parasites.

Villarino N, Schmidt NW.

Curr Immunol Rev. 2013 Aug;9(3):169-178.

20.

Regional variation in the correlation of antibody and T-cell responses to Trypanosoma cruzi.

Martin DL, Marks M, Galdos-Cardenas G, Gilman RH, Goodhew B, Ferrufino L, Halperin A, Sanchez G, Verastegui M, Escalante P, Naquira C, Levy MZ, Bern C.

Am J Trop Med Hyg. 2014 Jun;90(6):1074-81. doi: 10.4269/ajtmh.13-0391. Epub 2014 Apr 7.

Supplemental Content

Support Center